Celltrion said it has signed a joint research and development agreement with Basgen Bio, a big data company, to strengthen its bio data analysis capabilities.Under the contract, the two companies will form a joint research committee and conduct 10 related joint research and development projects over
The recent removal of bidding rules by the Vietnamese government is expected to accelerate the entry of Korean medical device companies into the Vietnamese market, industry watchers said.The Vietnamese Ministry of Health has eliminated government bidding regulations in response to complaints from th
A group of pharmacists, including those from the Korean Association of Pharmacists for Healthy Society, have submitted a civil petition to the Ministry of Food and Drug Safety to introduce the miscarriage-inducing drug mifepristone.The association said Thursday that Shin Hyung-geun and 171 members h
The Korea Exchange (KRX) said on Tuesday it updated the Kosdaq comprehensive public filing guidelines for the pharmaceutical and biotech sectors to enhance the integrity of clinical trial disclosures.The KRX had previously introduced the "Guidelines for Comprehensive Public Filing for the Biopharmac
After prosecutors charged members of a voice phishing group that made and supplied narcotic drinks to students in southern Seoul with “for-profit underage drug use” that could demand maximum death penalties, pediatricians welcomed it.These members are suspected of tricking 13 minors into taking drug
Four medical institutions in Daegu will be subject to administrative measures related to a female teenager’s death in an ambulance after failing to accept the patient on March 19.The Ministry of Health and Welfare said Thursday it would take administrative steps on four emergency care hospitals amon
Daiichi Sankyo Korea’s Enhertu (ingredient: trastuzumab druxtecan), a treatment for breast and gastric cancer, has passed the first gateway for winning insurance coverage, after garnering more than 50,000 votes of patients and guardians in a national online petition to push for reimbursement.The tre
Daewoong Pharmaceutical has started to attract talent from Indonesia and has hired 19 biopharmaceutical experts from the country to join their workforce in Korea, with the aim of enhancing their global R&D capabilities.The recruitment process comes after Daewoong selected Indonesia as a hub country
The Ministry of Food and Drug Safety has worked out a temporary permissible standard (daily dose) for atenolol-based hypertension drugs that caused controversy due to the detection of nitrosamine impurities.It decided not to withdraw them from the market.Oh Jeong-won, director of the Pharmaceutical
Glenwood Private Equity (PE) has been selected as the preferred bidder for an acquisition of LG Chem's diagnostic division, a pharmaceutical industry official said. LG Chem's diagnostics division operates various diagnostic reagents and polymerase chain reaction (PCR) equipment to test for allergic
Non-small cell lung cancer (NSCLC) has been one of the areas the treatments of which have not drawn much attention. The biggest reason: finding lung cancer patients in the early stage was difficult.According to national cancer statistics, about 45 percent of Korean lung cancer patients are stage 4 p
As the number of mpox cases continues to rise in Korea, the country's quarantine authorities have decided to extend the target group for the third-generation mpox vaccine to include sexual minorities.The quarantine authorities are using the third-generation mpox vaccines in two ways -- pre-exposure
“Enhertu (trastuzumab deruxtecan), an antibody-drug conjugate, demonstrated strong cell toxicity effects, bringing about new changes in HER2-positive metastatic breast cancer treatment that had had unmet clinical needs. Based on efficacy and safety in various clinical trials, Enhertu has already tak
SK Biopharmaceuticals said the Israeli Ministry of Health has approved the new drug application (NDA) for Xcopri (ingredient: cenobamate), a new drug for epilepsy.The application was submitted by SK Biopharmaceuticals’ Israeli partner Dexcel Ltd, and included six dosages -- 12.5mg, 25mg, 50mg, 100mg
Daewoong Pharmaceutical said it will build a third plant to expand the business of its botulinum toxin (BTX) Nabota and respond to the rising global demand.The third plant, in which the company will invest more than 100 billion won ($74.6 million) in construction, will be located in Hwaseong, Gyeong
Merck said it has signed a memorandum of understanding (MOU) with the Ministry of Trade, Industry and Energy (MOTIE) and the Daejeon government, to build a new Asia-Pacific bioprocessing center in Daejeon, some 140 km south of Seoul.The planned bioprocessing facility would support commercial manufac
Novo Nordisk Korea said it received the Ministry of Food and Drug Safety’s approval for Wegovy Prefilled Pen (ingredient: semaglutide) on Thursday last week. Wegovy, a once-weekly treatment for obesity, is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight m
AbbVie Korea has announced the successful integration of its business with Allergan Korea, and as of Monday, the two entities have merged into a single organization.The domestic merger follows AbbVie acquiring Allergan in May 2020.This year also marks the 10th anniversary of AbbVie's founding in 201
Daewoong Pharmaceutical said it launched its sodium-glucose cotransporter 2 (SGLT2) inhibitor drug, Envlo 0.3mg (ingredient: enavogliflozin), a diabetes treatment and Korea's 36th new drug, on Monday. The treatment is the first locally-developed SGLT-2 inhibitor.Earlier, Envlo received insurance cov
The Ministry of Food and Drug Safety and the U.S. Food and Drug Administration concluded a memorandum of cooperation (MOC) on medical products based on artificial intelligence last Thursday (local time).According to the Korean regulator on Tuesday, Minister Oh Yu-kyoung and Commissioner Robert M. Ca